RELIEF Study:
See how diabetes-related hospitalizations were significantly reduced after starting FreeStyle Libre systems*4.
RELIEF Study:
See how diabetes-related hospitalizations were significantly reduced after starting FreeStyle Libre systems*4.
IMMEDIATE RCT:
See how A1C was significantly reduced with FreeStyle Libre systems and DSME vs DSME alone in people with T2D*5.
FLASH-UK RCT:
See how people with T1D achieved significant clinical benefits with FreeStyle Libre systems vs BGM†6.
BGM = blood glucose monitoring; DSME = Diabetes Self-Management Education; T1D = Type 1 diabetes; T2D = Type 2 diabetes; RCT = randomized controlled trial
Not actual image of user.
Debra, T2D patient:
See how the FreeStyle Libre 3 system helped Debra better understand her glucose levels, leading to improved medication adherence and TIR‡7.
Not actual image of user.
Joe, T2D patient:
Learn how the FreeStyle Libre 3 system helped Joe improve and maintain glycemic control even with GLP-1 interruption‡7.
Not actual image of user.
Female 65-70, T2D patient:
Discover how the FreeStyle Libre 2 system helped stabilize glucose and improve well-being in a patient struggling with glycemic variability and obesity‡7.
Not actual image of user.
Ben, T1D patient, newly diagnosed:
Explore how the FreeStyle Libre 2 system helped a patient averse to BGM increase medication adherence and glucose monitoring‡§7.
Not actual image of user.
Male T2D patient, chronic CV conditions:
See how the FreeStyle Libre 2 system helped increase scanning (vs with BGM), control, and awareness, leading to improved health and lifestyle choices‡7.
CV = cardiovascular; GLP-1 = glucagon-like peptide-1; QOL = quality of life; TIR = time in (target) range.
Mark your calendar to meet industry experts, connect with peers, and learn more about our latest innovations.
* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
† Data from this study was collected with the outside US version of the FreeStyle Libre 2 system. FreeStyle Libre 3 has the same features as FreeStyle Libre 2 system. Therefore the study data is applicable to both products.
‡ Based on assessment and input from patient’s healthcare provider.
§ Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
References: 1. Bolinder, Jan, et al. "Novel Glucose-sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-masked, Randomised Controlled Trial." The Lancet 388, no. 10057 (2016): 2254-2263. https://doi.org/10.1016/S0140-6736(16)31535-5. 2. Evans, Mark, et al. "Reductions in HbA1c with flash glucose monitoring are sustained for up to 24 months: a meta-analysis of 75 real-world observational studies." Diabetes Therapy (April 2022). https://doi.org/10.1007/s13300-022-01253-9. 3. Haak, Thomas, et al. "Flash Glucose-sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 4. Riveline Jean-Pierre et. al. “Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study.” Diabetes Technology & Therapeutics 24, no. 9 (2022): 611–618. https://doi.org/10.1089/dia.2022.0085. 5. Aronson, Ronnie, et al. “IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial. Diabetes Obesity and Metabolism 25, no. 4 (2023): 1024–1031. https://doi.org/10.1111/dom.14949. 6. Leelarathna, Lalantha, et al. "Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes." New England Journal of Medicine 387, no. 16 (2022): 1477–1487. https://doi.org/10.1056/nejmoa2205650. 7. Data on file. Abbott Diabetes Care, Inc.
ADC-95730 v1.0
Important Safety Information
Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Get medical attention when appropriate. Abbott Customer Service: 855-632-8658 or visit FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v21.0
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
